ArticleCancer genetics2025

Analytical validation of the Belay Vantage™ assay for evaluation of MGMT promoter methylation using enzymatically converted tumorDNA from cerebrospinal fluid.

Kala F Schilter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.